The switch from the 7-valent pneumococcal conjugate vaccine, or PCV7, to the 13-valent pneumococcal conjugate vaccine, or PCV13, in children was associated with major declines in pneumococcal disease in U.S. adults, according to research published in Clinical Infectious Diseases.
Universal PCV7 immunization of birth cohorts began in 2000, and “the widespread use of the 7-valent pneumococcal conjugate vaccine among young children in the U.S. also resulted – via a herd effect – in reduced levels of [invasive pneumococcal diseases (IPD)] among older children and adults,” the researchers wrote. “However, by 2010, increasing numbers of cases of IPD due to non-vaccine serotypes began to erode the reductions in disease in both adults and children.”
This activity is supported by an educational grant from Fujifilm Medical Systems U.S.A., Inc.
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2018 Healio All Rights Reserved.